Utilize este identificador para referenciar este registo: https://hdl.handle.net/10316/107441
Título: Ugi Reaction Synthesis of Oxindole-Lactam Hybrids as Selective Butyrylcholinesterase Inhibitors
Autor: Brandão, Pedro 
López, Óscar
Leitzbach, Luisa
Stark, Holger
Fernández-Bolaños, José G.
Burke, Anthony J.
Pineiro, Marta 
Data: 11-Nov-2021
Editora: ACS American Chemical Society
Projeto: info:eu-repo/grantAgreement/FCT/POR_CENTRO/PD/BD/128490/2017/PT/Sustainable Asymmetric Catalytic Synthesis of Novel Oxindole Hybrids with Potential Biological Activity 
info:eu-repo/grantAgreement/FCT/UIDP/00313/2020 
UIDB/50006/2020 
UIDB/00313/2020 
Título da revista, periódico, livro ou evento: ACS Medicinal Chemistry Letters
Volume: 12
Número: 11
Resumo: Molecular hybridization is a valuable approach in drug discovery. Combining it with multicomponent reactions is highly desirable, since structurally diverse libraries can be attained efficiently in an eco-friendly manner. In this work, isatin is used as the key building block for the Ugi 4-center 3-component reaction synthesis of oxindole-lactam hybrids, under catalyst-free conditions. The resulting oxindole-β-lactam and oxindole-γ-lactam hybrids were evaluated for their potential to inhibit relevant central nervous system targets, namely cholinesterases and monoamine oxidases. Druglikeness evaluation was also performed, and compounds 4eca and 5dab exhibited great potential as selective butyrylcholinesterase inhibitors, at the low micromolar range, with an interesting predictive pharmacokinetic profile. Our findings herein reported suggest oxindole-lactam hybrids as new potential agents for the treatment of Alzheimer's disease.
URI: https://hdl.handle.net/10316/107441
ISSN: 1948-5875
DOI: 10.1021/acsmedchemlett.1c00344
Direitos: embargoedAccess
Aparece nas coleções:I&D CQC - Artigos em Revistas Internacionais

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato
Brandao2021ACSMedChemLett.pdf2.89 MBAdobe PDFVer/Abrir
Mostrar registo em formato completo

Google ScholarTM

Verificar

Altmetric

Altmetric


Este registo está protegido por Licença Creative Commons Creative Commons